In the search for innovative solutions for managing inflammatory dermatoses, acidifying the stratum corneum has emerged as a promising approach. Acidifying emollients are commonly used to regulate skin pH; however, lower pH levels are often linked to increased irritation.

A study published by the National Institutes of Health (NIH) studied whether lactobionic acid (LA), a "superacid" from the alpha-hydroxy acid (AHA) family, can effectively lower skin surface pH without irritating.

Study methodology

Researchers evaluated the safety and effectiveness of a 10% LA-containing emulsion formulated with alkyl polyglucosides (APGs), sugar-based emulsifiers known for their mildness. The study used both in vitro and in vivo methodologies:

What did the study reveal?

The study revealed promising findings regarding the effects of lactobionic acid:

This study supports the use of lactobionic acid as a safe and effective alternative to low-molecular AHAs in acidifying emollients. The findings suggest that a 10% LA-containing moisturiser can reduce skin pH without causing irritation or compromising the skin barrier, making it a promising addition to dermatological and cosmeceutical formulations.